Insights into axial spondyloarthritis features and the development of imaging evidence of sacroiliitis during long-term follow-up in routine clinical practice [0.03%]
Stan Corné Kieskamp,Marjan Jolanda Nijmeijer,Fréke Wink et al.
Stan Corné Kieskamp et al.
Immunoglobulin G and plasma glycome in early rheumatoid arthritis differ from matched controls and link less fat-free mass to an accelerated aging phenotype: an exploratory study [0.03%]
Sidra W Hashmi,Brian J Andonian,Mary M Thompson et al.
Sidra W Hashmi et al.
Interferon α-induced HERC6 provokes podocyte dysfunction via mitotic catastrophe in lupus nephritis [0.03%]
Xiaoquan Wei,Shuhui Wang,Wenkun Peng et al.
Xiaoquan Wei et al.
Characteristics and safety outcomes of rheumatoid arthritis patients treated with AMGEVITA® in the United Kingdom using data from a national register [0.03%]
Argentina E Servin,Mark Lillie,Ran Jin et al.
Argentina E Servin et al.
Cellular and molecular landscapes of inflammation in anterior cruciate ligament rupture patients are independent on concurrent meniscal injury [0.03%]
Nienke J T van Kooten,Arjen B Blom,Angela M Soares et al.
Nienke J T van Kooten et al.
Maarten O Mensink,Sytze de Roock,Julia Drylewicz et al.
Maarten O Mensink et al.
The DHCQ/HCQ metabolic ratio and CYP2C8 Genotype are associated with lipid profile improvement in systemic lupus erythematosus patients treated with hydroxychloroquine [0.03%]
Xue Zhao,Han Xie,Tengfei Shao et al.
Xue Zhao et al.
Serum citrullinated histone H3 as a biomarker of disease activity and renal outcome in microscopic polyangiitis and granulomatosis with polyangiitis [0.03%]
Oh Chan Kwon,Taejun Yoon,Jang Woo Ha et al.
Oh Chan Kwon et al.
Development and preliminary evaluation of a measure ofself-efficacy of Self-Management in ARThritis: SMART [0.03%]
Ramali Mendis,Tom Lynch,Asaduzzaman Khan et al.
Ramali Mendis et al.
Proportions of patients meeting definitions for progressive disease or improvement should be included in clinical trials for systemic sclerosis interstitial lung disease [0.03%]
Kathleen Morrisroe,Donald Tashkin,Murray Baron
Kathleen Morrisroe